Evidence map›Paper›PMID 41938516›Full record

ArticleInternational journal of medical sciences2026

Metabolomics Reveals the Anti-hepatic Fibrosis Mechanisms of

Yu-Ju Chen, Lo-Yun Chen, Ngoc-Thac Pham, John Louie Dela Vega, Federica Fulgheri, Ching-Chiung Wang, Maria Letizia Manca, Chia-Jung Lee

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yu-Ju ChenPh.D. Program in Clinical Drug Development of Herbal Medicine, Taipei Medical University, Taipei, Taiwan.
Lo-Yun ChenPh.D. Program in Clinical Drug Development of Herbal Medicine, Taipei Medical University, Taipei, Taiwan.
Ngoc-Thac PhamPh.D. Program in Clinical Drug Development of Herbal Medicine, Taipei Medical University, Taipei, Taiwan.
John Louie Dela VegaPh.D. Program in School of Pharmacy, Taipei Medical University, Taipei, Taiwan.
Federica FulgheriDepartment. of Life and Environmental Sciences, University of Cagliari, University Campus, S.P. Monserrato-Sestu Km 0.700, CA, Monserrato, 09042, Italy.
Ching-Chiung WangPh.D. Program in Clinical Drug Development of Herbal Medicine, Taipei Medical University, Taipei, Taiwan.
Maria Letizia MancaDepartment. of Life and Environmental Sciences, University of Cagliari, University Campus, S.P. Monserrato-Sestu Km 0.700, CA, Monserrato, 09042, Italy.
Chia-Jung LeePh.D. Program in Clinical Drug Development of Herbal Medicine, Taipei Medical University, Taipei, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Liver fibrosis is a progressive disorder characterized by excessive extracellular matrix (ECM) accumulation, leading to impaired liver function and potentially cirrhosis.

Indexed as

Liver CirrhosisPlant ExtractsPuerariaAnimalsCarbon TetrachlorideDisease Models, AnimalExtracellular MatrixHumansLiverMaleMetabolomicsMiceNetwork PharmacologyOxidative StressSignal TransductionCarbon TetrachloridePlant ExtractsAnti-liver fibrosisMetabolomicsNetwork pharmacologyPueraria lobata (Willd.) Ohwi

Identifiers

PMID41938516
PMCPMC13048894

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.